Pathological changes of monocrotaline-induced pulmonary hypertension in miniature pigs.
- Author:
Jin ZHAO
1
;
Rong LIU
;
Hongtao LI
;
Xinfeng ZHANG
;
Baohua LIU
;
Qinghong WU
;
Yuanxin QIAN
;
Weiwang GU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Hypertension, Pulmonary; chemically induced; pathology; Lung; pathology; Male; Monocrotaline; adverse effects; Myocardium; pathology; Swine; Swine, Miniature
- From: Journal of Southern Medical University 2012;32(6):867-869
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the pathological changes in the myocardial and pulmonary tissues in miniature pigs with chronic pulmonary hypertension induced by monocrotaline (MCT).
METHODSTwelve male miniature pigs (weigh 15.0-18.0 kg, aged 4.0-4.5 months) were examined for baseline mean pulmonary artery pressure (mPAP), followed by intraperitoneal injection of 10.0 mg/kg MCT in 10 randomly selected pigs. The mean pulmonary artery pressure at 4 and 8 weeks were determined, and the pathological changes in the myocardial and pulmonary tissues were observed.
RESULTSThe baseline mPAP of normal miniature pigs was 15.19∓0.70 mmHg. At 4 and 8 weeks after MCT injection, the sPAP and dPAP were 19.69∓2.47 mmHg and 25.62∓4.88 mmHg, respectively, and the mPAP increased significantly compared with that of the normal control group (P<0.01). Obvious pathological changes such as pulmonary hypertension and right ventricular hypertrophy were found in the pigs 4 weeks after MCT injection, and at 8 weeks, significant pathological changes occurred including right ventricular fibrosis and thickening of the tunica media of the pulmonary artery.
CONCLUSIONMCT can cause pulmonary hypertension in miniature pigs 8 weeks after drug administration, shown as increased pulmonary artery pressure and pulmonary vascular remodeling.